A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma

Clinical trial NCT00790218 · COMPLETED

Trial details

NCT number: NCT00790218
Sponsor: Can-Fite BioPharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2009-02-01
Primary completion: 2012-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.